Hemangioblastoma of the conus medullaris, Diagnosis and Therapeutic outcomes: a Systematic Review

Abstract

Introduction: Hemangioblastomas (HBs) are rare, usual essential nervous system tumours, which commonly set in the cerebellum. It exhibits various symptoms created on their anatomical position. Diagnosis of conus medullaris hemangioblastomas (CMHBs) commonly needs MRI, but treatment mainly involves surgical excision, rarely in combination with embolisation or radiosurgery. Microsurgical methods improve results that makes surgery the main, positive action for neurological rehabilitation.

Aim and objectives: This systematic review goals to measure and integrate current information regarding the diagnostic and treatment outcomes of CMHB.

Method: This systematic review examines CMHBs diagnosis, treatment, and diagnosis, that focus on precision and outcomes. It employs records such as PubMed and Scopus, it combines case studies and innovative study to make evidence-based control. The review highlights current diagnostic and medical developments, with the unbiassed of enhancing CMHB administration choices for clinicians and investigators.

Result: The study shows MRI as the preferred diagnostic tool, with high accuracy for tumour characteristics (p = 0.03). Complete resection was linked to better symptom relief (p = 0.01) compared to partial resection. Embolisation, with a p-value of 0.04, effectively reduced recurrence risk, while larger tumours were associated with higher complication rates (p = 0.01). MRI contrast improved survival outcomes (p = 0.01).

Conclusion: This study concludes that MRI, particularly with contrast, is crucial for accurately diagnosing conus medullaris hemangioblastomas (CMHBs), and complete surgical resection can bring the best outcomes for symptom relief and long-term recovery.